The International team counseled Alcobra Pharma Ltd in a unique transaction, known as a Reverse IPO.

Advocates Shy Baranov, Itamar Mei-Zahav and Boaz Shiffman of our Tel Aviv office, and Advocates Mitchell C. Stein, Howard Berkenblit and Douglas Stransky from our US office, accompanied the company, which is currently a registered company in Israel and traded on .NASDAQ, with novel technologies based on ribonucleic acid (RNA).